CMND
Clearmind Medicine Inc. - Common Shares (CMND)
$64
About Clearmind Medicine Inc. - Common Shares (CMND)
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize it as regulated medicines, foods, or supplements. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.
Details
Daily high
$1.79
Daily low
$1.63
Price at open
--
52 Week High
$524.00
52 Week Low
$1.63
Market cap
2.8M
Dividend yield
0.00%
Volume
198,090
Avg. volume
1.1M
P/E ratio
-.01
Clearmind Medicine Inc. - Common Shares News
Details
Daily high
$1.79
Daily low
$1.63
Price at open
--
52 Week High
$524.00
52 Week Low
$1.63
Market cap
2.8M
Dividend yield
0.00%
Volume
198,090
Avg. volume
1.1M
P/E ratio
-.01